European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Evotec (UK) Ltd., Abingdon

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Evotec (UK) Ltd.
Evotec OAI Ltd.
Oxford Asymmetry International plc
Oxford Asymmetry Ltd.

Register

Chp
Companies House 02674265
Lei
529900F5DPXM7W4RRK85

Address

114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, United Kingdom

Additional info

72.11
Research and experimental development on biotechnology

Financials

History

Legal Representatives

Marketing & Tech

Network

Loading network

Publications

8 Jan 2024
No longer Director: Werner Lanthaler
29 Nov 2023 also 17/08/2022, 12/08/2021, 08/10/2020, 04/10/2019, 27/09/2018, 30/06/2017, 16/06/2016, 03/10/2015, 12/08/2014, 26/07/2013, 05/09/2012, 21/03/2011, 28/04/2010, 28/03/2009, 06/05/2008, 09/05/2007, 30/06/2006, 27/06/2005
Full accounts made up to 2022-12-31
22 Nov 2023 also 22/11/2022, 03/12/2021, 01/12/2020, 22/11/2019, 22/11/2018, 30/11/2017
Confirmation statement made with no updates
30 Mar 2023
No longer Director: Ralph Enno Spillner
7 Dec 2022
Secretary: Mary Abdul · No longer Secretary (1)
5 Sept 2022
Director: Adam Stoten
2 Sept 2022
No longer Director: Christophe Muller
13 Apr 2021
Secretary (1) · No longer Secretary (1)
1 Sept 2020 via Liverpool School of Tropical Medicine
UK funding: Delivering Integrated Solutions for Human Infections
6 Apr 2020 via Evotec SE, also 03/05/2019
Shareholder: Evotec SE
1 Oct 2019 in Fts
EU funding (€79,299): 823712 - Compbiomed2 - a Centre of Excellence in Computational Biomedicine
1 Oct 2019 in Fts
EU funding (€51,982): 823712 - Compbiomed2 - a Centre of Excellence in Computational Biomedicine
1 Oct 2019 in Fts
EU funding (€2,590.55): 823712 - Compbiomed2 - a Centre of Excellence in Computational Biomedicine
6 Sept 2019
Change of details for Evotec Ag as a person with significant control
5 Aug 2019
Director: Craig Johnstone · Secretary (1) · No longer Secretary (1)
20 May 2019 in Hor
EU funding (€133,875): A Centre of Excellence in Computational Biomedicine
11 Feb 2019
Director: Christophe Muller · No longer Director: Mario E. C. Polywka
16 Nov 2018 in Hor
EU funding: Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections
18 Apr 2018 via Evotec AG, also 21/04/2017, 18/04/2016, 30/04/2015, 12/06/2014, 23/04/2013, 19/04/2012, 14/04/2011, 05/05/2010, 09/04/2009, 17/06/2008, 17/08/2007
Shareholder: Evotec AG
28 Nov 2016
Confirmation statement made with updates
25 Jul 2016 in Hor
EU funding (€131,288): A Centre of Excellence in Computational Biomedicine
18 Jul 2016
Director: Ralph Enno Spillner
30 Jun 2016
No longer Director: Colin Michael Bond
27 Nov 2015
Capital: £4,361,204
9 Dec 2014
Capital: £4,361,204
17 Oct 2014
Miscellaneous
5 Aug 2014
Secretary (1) · No longer Secretary (1)
24 Mar 2014
Patent: Preparation of Pyrrolo[2,3-b]Pyrazine and Pyrrolo[2,3-b]Pyridine Derivatives as Fgfr Inhibitors
6 Jan 2014
Secretary (1) · No longer Secretary (1)
9 Dec 2013
Address · Capital: £4,361,204
23 Sept 2013
Patent: 3-(Aryl- or Heteroaryl-Amino)-7-(3,5-Dimethoxyphenyl)Isoquinoline Derivatives AS Fgfr Inhibitors Useful for the Treatment of Proliferative Disorders or Dysplasia
23 Sept 2013
Patent: Phenyl- or Pyridyl- Pyrrolo[2,3B]Pyrazine Derivatives Useful in the Treatment or Prevention of Proliferative Disorders or Dysplasia
30 Nov 2012
Annual return made up to 2012-11-22 with full list of shareholders
6 Mar 2012
Declaration of satisfaction in full or in part of a mortgage or charge /full /charge no 5
29 Nov 2011
Annual return made up to 2011-11-22 with full list of shareholders · Director's details changed for Mr Colin Michael …
3 Aug 2011
Patent: Pyrazolopyridine Compounds AS PDE10A Inhibitors
24 Nov 2010
Annual return made up to 2010-11-22 with full list of shareholders · Secretary's details changed for Grant Nash
18 Aug 2010
Director: Colin Michael Bond · No longer Director (1)
26 Nov 2009
Annual return made up to 2009-11-22 with full list of shareholders · Director's details changed for Dr Werner Lanthaler
24 Apr 2009
Secretary (1) · No longer Secretary (1)
26 Mar 2009
Director: Werner Lanthaler
9 Mar 2009
Statement by directors · Miscellaneous · Solvency statement dated 27/02/09 · Resolutions · Resolutions
6 Jan 2009
No longer Director (1)
17 Dec 2008 also 21/12/2005
Return made up to 22/11/08; full list of members
3 Dec 2008
Miscellaneous · Solvency statement dated 20/11/08 · Statement by directors · Resolutions · Resolutions
22 Apr 2008
No longer Director (1)
6 Jan 2008 as Oxford Asymmetry International plc
Wordmark: “PROSPECTOR“
19 Dec 2007
Address
26 Oct 2007
New director appointed
9 Oct 2007
Address
11 Sept 2007
Director resigned
21 Dec 2006
Return made up to 22/11/06; full list of members · Location of register of members address changed
16 Feb 2006
Address
12 Aug 2005
Name: Evotec (UK) Ltd
6 Jun 2005 as Evotec OAI Ltd.
New director appointed · New director appointed · Director resigned

Mentions

27 May 2024
Direct parent: Evotec AG
27 May 2024
Ultimate parent: Evotec AG

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Evotec (UK) Ltd., Abingdon" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close